Tag: Biotechnology & Pharmaceutical Services Outsourcing Market Insights

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Are The Forecasted Market Size Estimates For The Biotechnology And Pharmaceutical Services Outsourcing Market Between 2025 And 2029?

The biotechnology and pharmaceutical services outsourcing market size has demonstrated robust growth in recent years. It is projected to increase from $66.87 billion in 2024 to $71.87 billion in 2025, registering a compound annual growth rate (CAGR) of 7.5%. The expansion witnessed in the historic period is attributable to the rising demand for therapeutic expertise and global trial design, an escalating number of orphan drug and rare disease trials, advancements in biologics and biosimilar development, an increased reliance on laboratory testing and analytical services, and the proliferation of virtual biotech firms.

The biotechnology and pharmaceutical services outsourcing market is anticipated to experience substantial expansion over the next few years. It is projected to reach $94.91 billion by 2029, growing at a compound annual growth rate (CAGR) of 7.2%. This growth within the forecast period can be attributed to heightened demands for swifter drug approvals, the globalization of clinical research endeavors, an increase in global clinical trial volumes, the rising outsourcing of phase I–IV trials, and an emphasis on adaptive and decentralized trial approaches. Significant trends during this period are expected to encompass the implementation of cloud-based platforms for real-time collaboration, the utilization of AI and ML in drug discovery and development, advanced bioinformatics and data analytics, the integration of automation and robotics in laboratory services, and the deployment of electronic data capture systems.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25709&type=smp

Which Drivers Are Supporting Growth Of The Biotechnology And Pharmaceutical Services Outsourcing Market?

Heightened engagement in clinical research is anticipated to propel the expansion of the biotechnology and pharmaceutical services outsourcing market. This type of research involves structured investigations with human subjects, aiming to deepen the understanding of health conditions and assess the efficacy and safety of medical treatments. The growing prevalence of chronic illnesses primarily drives this surge in clinical research, making the creation and evaluation of novel therapies crucial for improving patient outcomes. By offering access to specialized expertise and sophisticated facilities, the outsourcing of biotechnology and pharmaceutical services facilitates clinical research, enabling trials to be conducted efficiently, economically, and in compliance with regulations worldwide. For example, in November 2023, the Association of the British Pharmaceutical Industry, a UK-based trade association, reported that the UK experienced a 4.3% annual increase in industry-led clinical trials, rising from 394 in 2021 to 411 in 2022. Consequently, the escalating involvement in clinical research is a significant impetus behind the growth of the biotechnology and pharmaceutical services outsourcing market.

What Are The Different Segment Classifications Within The Biotechnology And Pharmaceutical Services Outsourcing Market?

The biotechnology and pharmaceutical services outsourcing market covered in this report is segmented –

1) By Service: Consulting, Regulatory Affairs, Product Design And Development, Auditing And Assessment, Product Maintenance, Training And Education, Other Services

2) By Application: Oncology, Neurology, Cardiovascular, Infectious Diseases

3) By End-Use: Pharma, Biotech

Subsegments:

1) By Consulting: Strategic Consulting, Market Access Consulting, Commercialization Strategy, Portfolio Management, Technology And Digital Transformation Consulting

2) By Regulatory Affairs: Regulatory Submissions, Compliance And Risk Management, Product Registration, Labeling And Packaging Review, Regulatory Intelligence

3) By Product Design And Development: Formulation Development, Preclinical Development, Bioprocess Development, Analytical Development, Drug Delivery System Design

4) By Auditing And Assessment: Good Manufacturing Practice (GMP) Audits, Good Clinical Practice (GCP) Audits, Quality System Audits, Supplier And Vendor Audits, Risk Assessments

5) By Product Maintenance: Lifecycle Management, Change Management, Technical Support, Software And IT System Updates, Compliance Monitoring

6) By Training And Education: Regulatory Training, Good Laboratory Practice (GLP) Training, Pharmacovigilance Training, Clinical Trial Training, Quality Management Systems Training

7) By Other Services: Intellectual Property Support, Medical Writing, Data Management And Biostatistics, Pharmacovigilance And Drug Safety, Translation And Localization Services

How Are Trends Influencing The Biotechnology And Pharmaceutical Services Outsourcing Market?

Leading companies in the biotechnology and pharmaceutical services outsourcing market are concentrating on developing advanced solutions, such as cloud-based systems, to support real-time collaboration and remote access. These cloud-based platforms are internet-driven systems that enable users to access and utilize computing resources, including storage, software, and processing power, without depending on local servers or devices. For instance, in March 2023, Charles River Labs, a US-based non-clinical contract research organization, introduced Apollo, a cloud-based platform aimed at enhancing toxicology studies. This platform offers a distinct advantage by simplifying client access to a broad array of study data, which assists in safety and toxicology evaluations. It incorporates self-service functionalities that allow users to independently track study progress, analyze data, and retrieve essential documents. Among its key tools is a quoting feature, facilitating more accurate and efficient budget planning.

Which Key Market Players Are Investing In Expansion And Innovation Of Biotechnology And Pharmaceutical Services Outsourcing Market?

Major companies operating in the biotechnology and pharmaceutical services outsourcing market are Thermo Fisher Scientific Inc., Boehringer Ingelheim, LabCorp Holdings, IQVIA Inc., ICON plc., Eurofins Scientific SE, Lonza Group Ltd., Syneos Health, Catalent Inc., Charles River Laboratories, Samsung Biologics Co. Ltd., WuXi Biologics, Recipharm AB, Medpace Holdings Inc., Curia Inc., CordenPharma Corp., Parexel International Ltd., Lachman Consultants, Concept Heidelberg GmbH, The Quantic Group Ltd.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/biotechnology-and-pharmaceutical-services-outsourcing-global-market-report

Which Geographies Are Emerging As Strong Markets For The Biotechnology And Pharmaceutical Services Outsourcing Industry?

North America was the largest region in the biotechnology and pharmaceutical services outsourcing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biotechnology and pharmaceutical services outsourcing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Biotechnology And Pharmaceutical Services Outsourcing Market Report:

https://www.thebusinessresearchcompany.com/customise?id=25709&type=smp

Browse Through More Reports Similar to the Global Biotechnology And Pharmaceutical Services Outsourcing Market 2025, By The Business Research Company

Advanced Therapeutics Pharmaceutical Outsourcing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/advanced-therapeutics-pharmaceutical-outsourcing-global-market-report

Biotechnology Services Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/biotechnology-services-global-market-report

Biologics Outsourcing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/biologics-outsourcing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

How Will The Biotechnology And Pharmaceutical Services Outsourcing Market Valuation Change Between Now And 2029?

In the past several years, there has been significant growth in the market size for outsourcing services in the pharmaceutical and biotechnology sectors. The market value is projected to increase from $66.87 billion in 2024 to $71.87 billion in 2025, with a compound annual growth rate (CAGR) of 7.5%. The historic market growth can be attributed to various factors. These include the growing demand for therapeutic expertise and global trial design, a rise in the number of trials for orphan drugs and rare diseases, surge in the development of biologics and biosimilars, an increased usage of lab testing and analytical services, and the expansion of virtual biotech companies.

A significant expansion is predicted in the forthcoming years for the biotechnology and pharmaceutical services outsourcing market, which is forecasted to reach a value of $94.91 billion in 2029, growing at a compound annual growth rate (CAGR) of 7.2%. The expected growth during this period can be linked to the escalating demand for expedited drug approvals, the widespread nature of clinical research activities, a rise in clinical trials on a global scale, an increasing trend towards outsourcing of phase I-IV trials, and an emphasis on adaptive and decentralized trials. The projection period will witness key trends such as the incorporation of cloud-based platforms for instantaneous collaboration, the application of AI and ML in drug research and development, advanced bioinformatics and data analytics, the use of automation and robotics in laboratory services, and the adoption of electronic data capture systems.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25709&type=smp

What Growth-Enabling Forces Are Impacting The Biotechnology And Pharmaceutical Services Outsourcing Market?

An uptick in clinical research, involving systematic investigations using human participants, is believed to be a key influencer for the expansion of the biotechnology and pharmaceutical services outsourcing market. The main driver for this rise in clinical research is the growing preponderance of chronic diseases, necessitating the creation and evaluation of new treatments for improved patient care. Outsourcing within the biotechnology and pharmaceutical arenas serves to facilitate clinical research, providing both specialized expertise and top-tier infrastructure. This in turn guarantees a global execution of trials that is not just efficient and affordable, but also compliant with regulatory standards. For instance, noted in November 2023 by the Association of the British Pharmaceutical Industry, a trade association based out of the UK, was a 4.3% yearly increase in industrial-powered clinical trials in the country, climbing from 394 trials in 2021 to 411 trials in 2022. Thus it’s evident that the surge in clinical research activities is stoking the biotechnology and pharmaceutical services outsourcing market’s growth.

What Are The Main Segment Classifications In The Biotechnology And Pharmaceutical Services Outsourcing Market?

The biotechnology and pharmaceutical services outsourcing market covered in this report is segmented –

1) By Service: Consulting, Regulatory Affairs, Product Design And Development, Auditing And Assessment, Product Maintenance, Training And Education, Other Services

2) By Application: Oncology, Neurology, Cardiovascular, Infectious Diseases

3) By End-Use: Pharma, Biotech

Subsegments:

1) By Consulting: Strategic Consulting, Market Access Consulting, Commercialization Strategy, Portfolio Management, Technology And Digital Transformation Consulting

2) By Regulatory Affairs: Regulatory Submissions, Compliance And Risk Management, Product Registration, Labeling And Packaging Review, Regulatory Intelligence

3) By Product Design And Development: Formulation Development, Preclinical Development, Bioprocess Development, Analytical Development, Drug Delivery System Design

4) By Auditing And Assessment: Good Manufacturing Practice (GMP) Audits, Good Clinical Practice (GCP) Audits, Quality System Audits, Supplier And Vendor Audits, Risk Assessments

5) By Product Maintenance: Lifecycle Management, Change Management, Technical Support, Software And IT System Updates, Compliance Monitoring

6) By Training And Education: Regulatory Training, Good Laboratory Practice (GLP) Training, Pharmacovigilance Training, Clinical Trial Training, Quality Management Systems Training

7) By Other Services: Intellectual Property Support, Medical Writing, Data Management And Biostatistics, Pharmacovigilance And Drug Safety, Translation And Localization Services

How Are Industry Trends Steering The Expansion Of The Biotechnology And Pharmaceutical Services Outsourcing Market?

Major firms in the biotechnology and pharmaceutical services outsourcing market are concentrating their efforts on developing innovative solutions like cloud-based platforms to facilitate real-time collaboration and remote access. These platforms are web-based systems giving users the ability to utilize computing resources such as storage, software, and processing power without the need for local servers or devices. For example, in March 2023, US-based non-clinical contract research organization Charles River Labs introduced Apollo, a cloud-based platform designed to enhance toxicology studies. It gives clients an edge by simplifying access to a broad array of study data, which is essential for safety and toxicology assessments. The platform comes with self-service options enabling users to independently track study progress, analyze data, and access crucial documents. One of its notable features is a quoting tool that assists in more precise and efficient budget planning.

Which Firms Are Driving Innovation Within The Biotechnology And Pharmaceutical Services Outsourcing Market?

Major companies operating in the biotechnology and pharmaceutical services outsourcing market are Thermo Fisher Scientific Inc., Boehringer Ingelheim, LabCorp Holdings, IQVIA Inc., ICON plc., Eurofins Scientific SE, Lonza Group Ltd., Syneos Health, Catalent Inc., Charles River Laboratories, Samsung Biologics Co. Ltd., WuXi Biologics, Recipharm AB, Medpace Holdings Inc., Curia Inc., CordenPharma Corp., Parexel International Ltd., Lachman Consultants, Concept Heidelberg GmbH, The Quantic Group Ltd.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/biotechnology-and-pharmaceutical-services-outsourcing-global-market-report

What Are The Emerging Regional Trends Driving The Biotechnology And Pharmaceutical Services Outsourcing Market?

North America was the largest region in the biotechnology and pharmaceutical services outsourcing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biotechnology and pharmaceutical services outsourcing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=25709&type=smp

Browse Through More Reports Similar to the Global Biotechnology And Pharmaceutical Services Outsourcing Market 2025, By The Business Research Company

Pharmaceutical Fill And Finish Outsourcing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pharmaceutical-fill-and-finish-outsourcing-global-market-report

Research And Development Outsourcing Services Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/research-and-development-outsourcing-services-global-market-report

Medical Device Outsourcing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/medical-device-outsourcing-global-market-report

About The Business Research Company:

With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Much Is the Global Biotechnology And Pharmaceutical Services Outsourcing Market Valued at Present and by 2029?

The market size of biotechnology and pharmaceutical services outsourcing has witnessed a robust growth in the past years. The market which is projected to increase from $66.87 billion in 2024 to $71.87 billion in 2025, will experience a compound annual growth rate (CAGR) of 7.5%. Factors such as the need for therapeutic expertise and global trial design, escalating count of orphan drug and rare disease trials, rising development of biologics and biosimilars, increased utilization of lab testing and analytical services, as well as the advancement of virtual biotech companies have contributed to this historical growth.

The biotechnology and pharmaceutical services outsourcing industry is projected to experience significant expansion in the coming years, with an anticipated market size of $94.91 billion by 2029, exhibiting a compound annual growth rate of 7.2%. The projected growth during this period is associated with the mounting pressure for expedited drug approvals, the international expansion of clinical research endeavors, an increase in the global volume of clinical trials, a surge in the outsourcing of phase I-IV trials, and the prioritization of adaptive and decentralized trials. The upcoming trends during this period incorporate the uptake of cloud-based platforms for instantaneous collaboration, the application of AI and Machine Learning in drug discovery and development phases, enhanced bioinformatics and data analytics, the introduction of automation and robotics into laboratory services, along with the implementation of electronic data capture systems.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25709&type=smp

#What Drivers Are Influencing Growth In The Biotechnology And Pharmaceutical Services Outsourcing Market?

The surge in clinical research activities is projected to contribute significantly to the expansion of the biotechnology and pharmaceutical services outsourcing market. Clinical research involves the participation of humans in a thorough inquiry, aiming to deepen our comprehension of health conditions and verify the efficacy and safety of medical procedures. The escalation in clinical research is predominantly fueled by the mounting prevalence of chronic diseases, requiring the invention and evaluation of novel therapies to improve patient care. The outsourcing of biotechnology and pharmaceutical services aids clinical research by delivering access to advanced infrastructure and expert opinion, thus ensuring the global execution of trials in an efficient, cost-effective, and regulation-abiding manner. For example, in November 2023, the UK experienced a 4.3% yearly growth in the number of industry-led clinical trials as per the Association of the British Pharmaceutical Industry, a trade association based in the UK. The count grew from 394 in 2021 to 411 in 2022. Hence, the amplified activity in clinical research propels the growth of the biotechnology and pharmaceutical services outsourcing market.

What Are The Main Segments Identified In The Biotechnology And Pharmaceutical Services Outsourcing Market Research?

The biotechnology and pharmaceutical services outsourcing market covered in this report is segmented –

1) By Service: Consulting, Regulatory Affairs, Product Design And Development, Auditing And Assessment, Product Maintenance, Training And Education, Other Services

2) By Application: Oncology, Neurology, Cardiovascular, Infectious Diseases

3) By End-Use: Pharma, Biotech

Subsegments:

1) By Consulting: Strategic Consulting, Market Access Consulting, Commercialization Strategy, Portfolio Management, Technology And Digital Transformation Consulting

2) By Regulatory Affairs: Regulatory Submissions, Compliance And Risk Management, Product Registration, Labeling And Packaging Review, Regulatory Intelligence

3) By Product Design And Development: Formulation Development, Preclinical Development, Bioprocess Development, Analytical Development, Drug Delivery System Design

4) By Auditing And Assessment: Good Manufacturing Practice (GMP) Audits, Good Clinical Practice (GCP) Audits, Quality System Audits, Supplier And Vendor Audits, Risk Assessments

5) By Product Maintenance: Lifecycle Management, Change Management, Technical Support, Software And IT System Updates, Compliance Monitoring

6) By Training And Education: Regulatory Training, Good Laboratory Practice (GLP) Training, Pharmacovigilance Training, Clinical Trial Training, Quality Management Systems Training

7) By Other Services: Intellectual Property Support, Medical Writing, Data Management And Biostatistics, Pharmacovigilance And Drug Safety, Translation And Localization Services

What Are The Leading Trends And Opportunities In The Biotechnology And Pharmaceutical Services Outsourcing Sector?

In the biotechnology and pharmaceutical services outsourcing market, leading firms are concentrating on creating innovative solutions like cloud-based platforms. These platforms, accessed via the internet, enable users to utilize computing resources such as storage, software and processing power, bypassing the need for local servers or devices. For example, Charles River Labs, a non-clinical contract research organization based in the U.S., unveiled a cloud-based platform named Apollo in March 2023 to enhance toxicology studies. This platform offers a unique benefit by facilitating clients’ access to a broad array of study data, aiding in safety and toxicology evaluations. The platform comes with self-service attributes that empower users to track the progress of studies, analyze data, and independently retrieve crucial documents. A standout feature of this platform is a quoting tool, fostering more precise and efficient budget planning.

Which Companies Play A Key Role In The Development Of The Biotechnology And Pharmaceutical Services Outsourcing Market?

Major companies operating in the biotechnology and pharmaceutical services outsourcing market are Thermo Fisher Scientific Inc., Boehringer Ingelheim, LabCorp Holdings, IQVIA Inc., ICON plc., Eurofins Scientific SE, Lonza Group Ltd., Syneos Health, Catalent Inc., Charles River Laboratories, Samsung Biologics Co. Ltd., WuXi Biologics, Recipharm AB, Medpace Holdings Inc., Curia Inc., CordenPharma Corp., Parexel International Ltd., Lachman Consultants, Concept Heidelberg GmbH, The Quantic Group Ltd.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/biotechnology-and-pharmaceutical-services-outsourcing-global-market-report

What Are The Key Regional Developments Shaping The Biotechnology And Pharmaceutical Services Outsourcing Market?

North America was the largest region in the biotechnology and pharmaceutical services outsourcing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biotechnology and pharmaceutical services outsourcing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=25709&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model